Variant report
Variant | esv3345939 |
---|---|
Chromosome Location | chr11:71119404-71123802 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:71121445-71121846 | K562 | blood: | n/a | n/a |
2 | BRCA1 | chr11:71121368-71121550 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr11:71121577-71121717 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr11:71121493-71121718 | A549 | lung: | n/a | n/a |
5 | CREB1 | chr11:71121296-71121778 | K562 | blood: | n/a | n/a |
6 | CREB1 | chr11:71121322-71121784 | HepG2 | liver: | n/a | n/a |
7 | CREB1 | chr11:71121367-71121872 | GM12878 | blood: | n/a | n/a |
8 | CTCF | chr11:71122685-71122743 | GM20000 | blood: | n/a | n/a |
9 | CTCF | chr11:71123280-71123430 | GM12865 | blood: | n/a | n/a |
10 | GATA3 | chr11:71121546-71121978 | SH-SY5Y | brain: | n/a | n/a |
11 | JUN | chr11:71121428-71121943 | HepG2 | liver: | n/a | chr11:71121622-71121635 |
12 | JUND | chr11:71121359-71121960 | HepG2 | liver: | n/a | n/a |
13 | JUND | chr11:71121633-71121640 | H1-hESC | embryonic stem cell: | n/a | n/a |
14 | MAFF | chr11:71121359-71121669 | HepG2 | liver: | n/a | n/a |
15 | MAFF | chr11:71120194-71120413 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr11:71120166-71120432 | HepG2 | liver: | n/a | chr11:71120308-71120323 |
17 | MAFK | chr11:71120168-71120390 | HepG2 | liver: | n/a | chr11:71120308-71120323 |
18 | MAFK | chr11:71121387-71121719 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr11:71121454-71121625 | HepG2 | liver: | n/a | n/a |
20 | NFE2 | chr11:71123646-71123655 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr11:71121199-71122087 | H1-neurons | neurons: | n/a | n/a |
22 | POLR2A | chr11:71121277-71122028 | H1-neurons | neurons: | n/a | n/a |
23 | SUZ12 | chr11:71121398-71121841 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000172900 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186345813 | chr11:71119831-71119832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374768428 | chr11:71119832-71119833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570614382 | chr11:71119862-71119863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571764844 | chr11:71119876-71119877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75773448 | chr11:71119879-71119880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534839651 | chr11:71119886-71119887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542587710 | chr11:71119891-71119892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568933342 | chr11:71119922-71119923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142987755 | chr11:71119927-71119928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs146087923 | chr11:71119932-71119933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148316858 | chr11:71119990-71119991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141478931 | chr11:71119991-71119992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117991852 | chr11:71120029-71120030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189647582 | chr11:71120034-71120035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544347077 | chr11:71120042-71120043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs57710575 | chr11:71120070-71120071 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs115710156 | chr11:71120072-71120073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1790364 | chr11:71120095-71120096 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs561289466 | chr11:71120104-71120105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528461011 | chr11:71120116-71120117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79947172 | chr11:71120117-71120118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565528677 | chr11:71120130-71120131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532645352 | chr11:71120202-71120203 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs4944044 | chr11:71120213-71120214 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs59751086 | chr11:71120235-71120236 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs375539030 | chr11:71120262-71120263 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs529716377 | chr11:71120267-71120268 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs557693708 | chr11:71120270-71120271 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs1792248 | chr11:71120287-71120288 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs1792249 | chr11:71120298-71120299 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs564567008 | chr11:71120333-71120334 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs150811544 | chr11:71120464-71120465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549942902 | chr11:71120479-71120480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181704174 | chr11:71120487-71120488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139257513 | chr11:71120504-71120505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528670856 | chr11:71120505-71120506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144504553 | chr11:71120537-71120538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77423560 | chr11:71120538-71120539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147443140 | chr11:71120539-71120540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555061007 | chr11:71120546-71120547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75283013 | chr11:71120565-71120566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115549835 | chr11:71120581-71120582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139641855 | chr11:71120632-71120633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77731984 | chr11:71120652-71120653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540797018 | chr11:71120672-71120673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145263954 | chr11:71120734-71120735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544510730 | chr11:71120737-71120738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145008867 | chr11:71120738-71120739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562762168 | chr11:71120759-71120760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186895004 | chr11:71120760-71120761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71119800-71120400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr11:71120000-71120400 | Enhancers | Brain Substantia Nigra | brain |
3 | chr11:71120000-71120600 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr11:71120000-71120800 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr11:71121000-71121400 | Weak transcription | Fetal Kidney | kidney |
6 | chr11:71121400-71121800 | ZNF genes & repeats | Fetal Kidney | kidney |
7 | chr11:71123600-71139600 | Weak transcription | Right Atrium | heart |